Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2016

01-10-2016 | Letter to the Editor

Investigation of each histological type in undifferentiated early gastric cancer and validity of diagnosis of the disease range

Authors: Yoshikazu Yoshifuku, Yoji Sanomura, Shiro Oka, Shinji Tanaka, Kazuaki Chayama

Published in: Gastric Cancer | Issue 4/2016

Login to get access

Excerpt

To the editor …
Literature
1.
Horiuchi Y, Fujisaki J, Yamamoto N, Shimizu T, Miyamoto Y, Tomida H, et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2015. doi:10.​1007/​s10120-015-0488-x.CrossRef
2.
Oka S, Tanaka S, Higashiyama M, Numata N, Sanomura Y, Arihiro K, et al. Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes. Surg Endosc. 2014;28:639–47.CrossRef
3.
Choi MS, Hong SJ, Han JP, Song JY, Kim DY, Seo SW, et al. Therapeutic outcomes of endoscopic submucosal dissection in undifferentiated-type early gastric cancer. Korean J Gastroenterol. 2013;61:196–202 (in Korean).CrossRef
4.
Wen J, Linghu EQ, Yang YS, Liu QS, Yang J, Lu ZS. Associated risk factor analysis for positive resection margins after endoscopic submucosal dissection in early-stage gastric cancer. J BUON. 2015;20:421–7.PubMed
5.
Kakushima N, Ono H, Tanaka M, Takizawa K, Yamaguchi Y, Matsubayashi H. Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection. Dig Endosc. 2011;23:227–32.CrossRef
6.
Yun GW, Kim JH, Lee YC, Lee SK, Shin SK, Park JC, et al. What are the risk factors for residual tumor cells after endoscopic complete resection in gastric epithelial neoplasia? Surg Endosc. 2015;29:487–92.CrossRef
Metadata
Title
Investigation of each histological type in undifferentiated early gastric cancer and validity of diagnosis of the disease range
Authors
Yoshikazu Yoshifuku
Yoji Sanomura
Shiro Oka
Shinji Tanaka
Kazuaki Chayama
Publication date
01-10-2016
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 4/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0568-y

Other articles of this Issue 4/2016

Gastric Cancer 4/2016 Go to the issue

Original Article

Portomesenteric vein thrombosis after gastric surgery

Original Article

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer

Original Article

Epstein–Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer

Original Article

Auxiliary diagnosis of lymph node metastasis in early gastric cancer using quantitative evaluation of sentinel node radioactivity

Original Article

Clinical significance of the anterosuperior lymph nodes along the common hepatic artery identified by sentinel node mapping in patients with gastric cancer

Original Article

Is signet-ring cell carcinoma a specific entity among gastric cancers?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits